(AOF) – MaaT Pharma, a late clinical stage biotechnology company, announces the appointment of Jonathan Chriqui, PharmD, to the position of chief business officer and member of the management team. He will be responsible for MaaT Pharma’s business development and partnership strategies, as well as promoting MaaT Pharma’s innovations within the microbiota industry. Previously, he served as operational director and chief business officer at Somagenetix in Zurich, Switzerland, developing gene therapy for rare diseases in immunology, neurology and oncology.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
